MURRIETA, CA–Dec 2, 2008 — CLX Pharma, Inc. (OTC BB:CLXN.OB ), which is focused on the product management and distribution of unique clinical diagnostic testing products, today announced the close of the company’s acquisition of ThyroTest®, a rapid thyroid st…
Diagnostics, Acquisitions
CLX Medical, ThyroTec, ThyroTest, thyroid stimulating hormone

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “CLX Medical, Inc. Announces Close of ThyroTest(R) Acquisition”
Leave a Comment